IMMUNE RESPONSE CORP 4
4 · IMMUNE RESPONSE CORP · Filed Jul 20, 2005
Insider Transaction Report
Form 4
THEOFAN GEORGIA
VP, Clinical Development
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2005-07-18+100,000→ 100,000 totalExercise: $0.74From: 2005-07-18Exp: 2015-07-18→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option is 25% vested on grant date. The remaining 75% will vest daily over a 2-year period.